Interleukin-10 plays a crucial role in suppression of experimental autoimmune encephalomyelitis by Bowman-Birk inhibitor

Journal of Neuroimmunology

Volumn 245, Issue 1-2, 2012, Pages 1-7

  Dai, Hong ^a   Ciric, Bogoljub ^a   Zhang, Guang Xian ^a   Rostami, Abdolmohamad ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Bowman Birk inhibitor; Experimental autoimmune encephalomyelitis; Interleukin 10; Th17; Tregs

Indexed keywords

BOWMAN BIRK INHIBITOR; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; PHOSPHATE BUFFERED SALINE; TRANSCRIPTION FACTOR FOXP3;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CELL COUNT; CELL INFILTRATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; IMMUNOREGULATION; INFLAMMATORY CELL; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH17 CELL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-10; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PRIMARY CELL CULTURE; TRYPSIN INHIBITOR, BOWMAN-BIRK SOYBEAN; TRYPSIN INHIBITORS;

EID: 84862786017     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2012.01.005     Document Type: Article

References (43)

1. Akirav E.M., Bergman C.M., Hill M., Ruddle N.H. Depletion of CD4(+)CD25(+) T cells exacerbates experimental autoimmune encephalomyelitis induced by mouse, but not rat, antigens. J. Neurosci. Res. 2009, 87:3511-3519.
2. Anderson A.C., Reddy J., Nazareno R., Sobel R.A., Nicholson L.B., Kuchroo V.K. IL-10 plays an important role in the homeostatic regulation of the autoreactive repertoire in naive mice. J. Immunol. 2004, 173:828-834.
3. Anderton S.M. Treg and T-effector cells in autoimmune CNS inflammation: a delicate balance, easily disturbed. Eur. J. Immunol. 2010, 40:3321-3324.
4. Axtell R.C., de Jong B.A., Boniface K., van der Voort L.F., Bhat R., De Sarno P., Naves R., Han M., Zhong F., Castellanos J.G., Mair R., Christakos A., Kolkowitz I., Katz L., Killestein J., Polman C.H., de Waal Malefyt R., Steinman L., Raman C. T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis. Nat. Med. 2010, 16:406-412.
5. Bettelli E., Das M.P., Howard E.D., Weiner H.L., Sobel R.A., Kuchroo V.K. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J. Immunol. 1998, 161:3299-3306.
6. Birk Y. The Bowman-Birk inhibitor trypsin- and chymotrypsin-inhibitor from soybeans. Int. J. Pept. Protein Res. 1985, 25:113-131.
7. Cohen J.A., Chun J. Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis. Ann. Neurol. 2011, 69:759-777.
8. Croxford J.L., Feldmann M., Chernajovsky Y., Baker D. Different therapeutic outcomes in experimental allergic encephalomyelitis dependent upon the mode of delivery of IL-10: a comparison of the effects of protein, adenoviral or retroviral IL-10 delivery into the central nervous system. J. Immunol. 2001, 166:4124-4130.
9. Cruz-Orengo L., Holman D.W., Dorsey D., Zhou L., Zhang P., Wright M., McCandless E.E., Patel J.R., Luker G.D., Littman D.R., Russell J.H., Klein R.S. CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity. J. Exp. Med. 2011, 208:327-339.
10. Cua D.J., Groux H., Hinton D.R., Stohlman S.A., Coffman R.L. Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis. J. Exp. Med. 1999, 189:1005-1010.
11. Dai H., Zhu H., Lei P., Yagita H., Liu J., Wen X., Zhou W., Gong F., Shen G., Fang M. Programmed death-1 signaling is essential for the skin allograft protection by alternatively activated dendritic cell infusion in mice. Transplantation 2009, 88:864-873.
12. Dai H., Ciric B., Zhang G.-X., Rostami A. Bowman-Birk inhibitor attenuates experimental autoimmune encephalomyelitis by delaying infiltration of inflammatory cells into the CNS. Immunol. Res. 2011, 10.1007/s12026-011-8254-6.
13. Daly N.L., Chen Y.K., Foley F.M., Bansal P.S., Bharathi R., Clark R.J., Sommerhoff C.P., Craik D.J. The absolute structural requirement for a proline in the P3'-position of Bowman-Birk protease inhibitors is surmounted in the minimized SFTI-1 scaffold. J. Biol. Chem. 2006, 281:23668-23675.
14. de Waal Malefyt R., Haanen J., Spits H., Roncarolo M., te Velde A., Figdor C., Johnson K., Kastelein R., Hans Yssel H., de Vries J.E. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 1991, 174:915-924.
15. El-behi M., Ciric B., Yu S., Zhang G.X., Fitzgerald D.C., Rostami A. Differential effect of IL-27 on developing versus committed Th17 cells. J. Immunol. 2009, 183:4957-4967.
16. El-behi M., Rostami A., Ciric B. Current views on the roles of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. J. Neuroimmune Pharmacol. 2010, 5:189-197.
17. El-Behi M., Ciric B., Dai H., Yan Y., Cullimore M., Safavi F., Zhang G.X., Dittel B.N., Rostami A. The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat. Immunol. 2011, 12:568-575.
18. Ephrem A., Chamat S., Miquel C., Fisson S., Mouthon L., Caligiuri G., Delignat S., Elluru S., Bayry J., Lacroix-Desmazes S., Cohen J.L., Salomon B.L., Kazatchkine M.D., Kaveri S.V., Misra N. Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis. Blood 2008, 111:715-722.
19. Fiorentino D.F., Zlotnik A., Vieira P., Mosmann T.R., Howard M., Moore K.W., O'Garra A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 1991, 146:3444-3451.
20. Fontenot J.D., Dooley J.L., Farr A.G., Rudensky A.Y. Developmental regulation of Foxp3 expression during ontogeny. J. Exp. Med. 2005, 202:901-906.
21. Keegan B.M., Noseworthy J.H. Multiple sclerosis. Annu. Rev. Med. 2002, 53:285-302.
22. Komiyama Y., Nakae S., Matsuki T., Nambu A., Ishigame H., Kakuta S., Sudo K., Iwakura Y. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 2006, 177:566-573.
23. Kroenke M.A., Carlson T.J., Andjelkovic A.V., Segal B.M. IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J. Exp. Med. 2008, 205:1535-1541.
24. Larionova N.I., Gladysheva I.P., Tikhonova T.V., Kazanskaia N.F. Inhibition of cathepsin G and elastase from human granulocytes by multiple forms of the Bowman-Birk type of soy inhibiton. Biokhimiia 1993, 58:1437-1444.
25. Losso J.N. The biochemical and functional food properties of the Bowman-Birk inhibitor. Crit. Rev. Food Sci. Nutr. 2008, 48:94-118.
26. Mahnke K., Qian Y., Knop J., Enk A.H. Induction of CD4+/CD25+regulatory T cells by targeting of antigens to immature dendritic cells. Blood 2003, 101:4862-4869.
27. Marin-Manzano M.C., Ruiz R., Jimenez E., Rubio L.A., Clemente A. Anti-carcinogenic soyabean Bowman-Birk inhibitors survive faecal fermentation in their active form and do not affect the microbiota composition in vitro. Br. J. Nutr. 2009, 101:967-971.
28. Matejuk A., Buenafe A.C., Dwyer J., Ito A., Silverman M., Zamora A., Subramanian S., Vandenbark A.A., Offner H. Endogenous CD4+BV8S2- T cells from TG BV8S2+ donors confer complete protection against spontaneous experimental encephalomyelitis (Sp-EAE) in TCR transgenic, RAG-/- mice. J. Neurosci. Res. 2003, 71:89-103.
29. McGeachy M.J., Anderton S.M. Cytokines in the induction and resolution of experimental autoimmune encephalomyelitis. Cytokine 2005, 32:81-84.
30. Mekala D.J., Alli R.S., Geiger T.L. IL-10-dependent suppression of experimental allergic encephalomyelitis by Th2-differentiated, anti-TCR redirected T lymphocytes. J. Immunol. 2005, 174:3789-3797.
31. Mendel I., Shevach E.M. The IL-10-producing competence of Th2 cells generated in vitro is IL-4 dependent. Eur. J. Immunol. 2002, 32:3216-3224.
32. Park J.H., Jeong H.J., Lumen B.O. J. Agric. Food Chem. 2007, 55:10703-10706.
33. Peron Jean Pierre S., Yang Kayong, Chen Mei-Ling, Brandao Wesley Nogueira, Basso Alexandre S., Commodaro Alessandra G., Weiner Howard L., Rizzo Luiz V. Oral tolerance reduces Th17 cells as well as the overall inflammation in the central nervous system of EAE mice. J. Neuroimmunol. 2010, 227:10-17.
34. Qi R.F., Song Z.W., Chi C.W. Structural features and molecular evolution of Bowman-Birk protease inhibitors and their potential application. Acta Biochim. Biophys. Sin. 2005, 37:283-292. (Shanghai.).
35. Rynda-Apple A., Huarte E., Maddaloni M., Callis G., Skyberg J.A., Pascual D.W. Active immunization using a single dose immunotherapeutic abates established EAE via IL-10 and regulatory T cells. Eur. J. Immunol. 2010, 41:313-323.
36. Sakaguchi S., Yamaguchi T., Nomura T., Ono M. Regulatory T cells and immune tolerance. Cell 2008, 133:775-787.
37. Shevach E.M. Regulatory T cells in autoimmmunity. Annu. Rev. Immunol. 2000, 18:423-44918.
38. Stephens L.A., Malpass K.H., Anderton S.M. Curing CNS autoimmune disease with myelin-reactive Foxp3+ Treg. Eur. J. Immunol. 2009, 39:1108-1117.
39. Touil T., Ciric B., Ventura E., Shindler K.S., Gran B., Rostami A. Bowman-Birk inhibitor suppresses autoimmune inflammation and neuronal loss in a mouse model of multiple sclerosis. J. Neurol. Sci. 2008, 271:191-202.
40. Vandenbark A.A., Finn T., Barnes D., Culbertson N., Chou Y.K., Hicks K., Bakke A., Mass M., Whitham R., Offner H., Bourdette D. Diminished frequency of interleukin-10-secreting, T-cell receptor peptide-reactive T cells in multiple sclerosis patients might allow expansion of activated memory T cells bearing the cognate BV gene. J. Neurosci. Res. 2001, 66:171-176.
41. Ware J.H., Wan X.S., Rubin H., Schechter N.M., Kennedy A.R. Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase. Arch. Biochem. Biophys. 1997, 344:133-138.
42. Zhang X., Koldzic D.N., Izikson L., Reddy J., Nazareno R.F., Sakaguchi S., Kuchroo V.K., Weiner H.L. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells. Int. Immunol. 2004, 16:249-256.
43. Zhu H., Qiu W., Lei P., Zhou W., Wen X., He F., Li L., Dai H., Shen G., Gong F. IL-10 gene modified dendritic cells inhibit T helper type 1-mediated alloimmune responses and promote immunological tolerance in diabetes. Cell. Mol. Immunol. 2008, 5:41-46.